FIRST AMENDMENT TO AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestors Rights Agreement |
|
|
|
You are currently viewing: This Investors Rights Agreement involves
SGX PHARMACEUTICALS, INC. | Oxford Finance Corporation. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here. |
|
|
|
Search Investors Rights Agreement by:
EXHIBIT 4.9
First Amendment to
Amended and Restated Investor Rights
Agreement
This First Amendment to the Amended and
Restated Investor Rights Agreement (the “Amendment”)
is made effective as of October 31, 2005, and is entered into by and among
SGX Pharmaceuticals, Inc.,
a Delaware corporation, previously known as Structural GenomiX, Inc. (the “Company”),
certain holders of the Company’s Series A Preferred Stock (“Series A
Preferred”), and certain holders of the Company’s
Series B Preferred Stock (“Series B Preferred”)
(which parties are hereinafter collectively referred to as the “Original
Parties”).
Whereas, the Original Parties have
previously entered into that certain Amended and Restated Investor Rights
Agreement, dated April 21, 2005 (the “Investor Rights
Agreement”);
Whereas, the Company, Silicon
Valley Bank (“SVB”) and Oxford Finance Corporation (“Oxford”)
have entered into a Loan and Security Agreement dated September 16, 2005
(the “Loan Agreement”); and
Whereas, pursuant to the Loan
Agreement, the Company agreed to issue certain warrants to SVB and Oxford and
to solicit the requisite consent of the parties to the Investor Rights
Agreement to add SVB and Oxford as parties to the Investor Rights Agreement to
provide such parties with those certain incidental, or “Piggyback,”
registration rights pursuant to and as set forth therein.
Now, therefore, in consideration of
the foregoing premises and the mutual covenants and conditions herein, the
parties hereto hereby agree that:
|
1. |
|
Capitalized
terms not defined herein shall have the meaning ascribed to them in the
Investor Rights Agreement. |
|
|
|
|
|
2. |
|
SVB and Oxford
shall become parties to the Investor Rights Agreement and the definition of
“Holder” in Section 1 of the Investor Rights Agreement shall
include SVB and Oxford; provided, however, that neither SVB nor Oxford
(nor any permitted transferee or assignee of SVB or Oxford) shall be deemed a
Holder for purposes of Section 2.2 or 2.4 of the Investor Rights
Agreement. |
|
|
|
|
|
3. |
|
The definition
of “Registrable Securities” in Section 1.1 of the Investor
Rights Agreement shall be replaced in its entirety with the following: |
““Registrable
Securities” means the (a) Common Stock of the Company issued
or issuable upon conversion of the Shares; (b) Bridge Converted Common
Stock; (c) Common Stock of the Company issued or issuable upon conversion
of the Conversion Securities (as those securities are defined in the
Convertible Promissory Note issued by the Company to mHoldings Trust (“mHoldings”)
dated December 21, 2001 (the “Millennium Note”)
(or in the event the Conversion Securities (as those securities are defined in
the Millennium Note) consist of the Company’s Common Stock, the
Conversion Securities (as those securities are defined in the Millennium
Note)); (d) Common Stock of the Company issued or issuable upon conversion
of the Warrant Securities (or in the event the Warrant
1.
Securities consist of the
Company’s Common Stock, the Warrant Securities), provided, however, that
any such shares of Common Stock or Warrant Securities issued upon exercise of
the Lender Warrants (or upon conversion of the Warrant Securities issued upon
exercise thereof) shall not be deemed Registrable Securities for purposes of
Section 2.2 or 2.4 hereof; and (e) Common Stock of the Company issued
as (or issuable upon the conversion or exercise of any warrant, right or other
security which is issued as) a dividend or other distribution with respect to,
or in exchange for or in replacement of, such above-described securities.
Notwithstanding the foregoing, Registrable Securities shall not include any
securities sold by a person to the public either pursuant to a registration
statement or Rule 144 or sold in a private transaction in which the transferor’s
rights under Section 2 of this Agreement are not assigned.”
|
4. |
|
The definition
of “Shares” in Section 1.1 of the Investor Rights Agreement
shall be replaced in its entirety with the following: |
““Shares”
shall mean (a) the Series A Stock and Series B Stock now
held or hereafter acquired by the Investors listed on Exhibit A hereto and their
permitted assigns; (b) the Pre-Series B Conversion Preferred Stock
held by the Investors listed on Exhibit A
hereto and their permitted assigns; (c) the Company securities issuable
upon exercise of the Warrant and the Lenders Warrants (the “Warrant
Securities”); and (d) the Conversion Securities (as those
securities are defined in the Millennium Note) issued pursuant to the
Millennium Note to mHoldings (or its permitted assigns).”
|
5. |
|
The following
definition shall be added to Section 1.1 of the Investor Rights
Agreement immediately following the definition of “Initial
Offering”: |
““Lender
Warrants” shall mean those certain warrants issued to Silicon
Valley Bank and Oxford Finance Corporation (or their respective permitted
assigns) pursuant to that certain Loan and Security Agreement dated as of
September 16, 2005 by and among the Company, Silicon Valley Bank and
Oxford Finance Corporation.”
|
6. |
|
By executing
this Amendment, each of SVB and Oxford agree to be bound by the provisions of
the Investor Rights Agreement, as amended by this Amendment (and as may be
subsequently amended from time to time), including without limitation the
provisions of Section 2.13 thereof. |
|
|
|
|
|
7. |
|
This Amendment
may be executed in any number of counterparts, each of which shall be an
original, but all of which together shall constitute one instrument. Except
as specifically amended by this Amendment, the terms and conditions of the
Investor Rights Agreement shall remain unchanged and in full force and
effect. This Amendment shall be governed by and construed in accordance with
the laws of the State of California as applied to contracts among California
residents entered into and performed entirely within California. |
2.
In Witness Whereof, the parties
hereto have executed this First
Amendment to the Amended
and Restated Investor Rights Agreement effective as of the day and
year first set forth above.
Company:
|
|
|
|
|
|
|
|
|
SGX
Pharmaceuticals, Inc. |
|
|
||||
|
|
|
|
|
|
|
|
|
By: |
|
/s/ Michael Grey |
|
|
||
|
|
|
|
|
|
||
|
|
|
Name: |
|
Michael Grey |
|
|
|
|
|
Title: |
|
President and Chief
Executive Officer |
|
|
[Signature Page to First
Amendment to Amended and Restated Investor Rights Agreement]
In Witness Whereof, the parties
hereto have executed this First
Amendment to the Amended and Restated Investor Rights Agreement
effective as of the day and year first set forth above.
|
|
|
|
|
|
|
|
|
Investors/Holders: |
|
|
||||
|
|
|
|
|
|
|
|
|
ALEXANDRIA REAL ESTATE
EQUITIES, L.P., |
|
|
||||
|
a Delaware limited
partnership |
|
|
||||
|
|
|
|
|
|
|
|
|
By: |
|
ARE-QRS CORP., |
|
|
||
|
|
|
a Maryland corporation,
general partner |
|
|
||
|
|
|
|
|
|
|
|
|
|
|
By: |
|
/s/ Etsuko Mason |
|
|
|
|
|
|
|
Etsuko Mason |
|
|
|
|
|
|
|
Vice President, Treasurer
and |
|
|
|
|
|
|
|
Assistant Secretary |
|
|
[Signature Page to First
Amendment to Amended and Restated Investor Rights Agreement]
In Witness Whereof, the parties
hereto have executed this First
Amendment to the Amended and Restated Investor Rights Agreement
effective as of the day and year first set forth above.
|
|
|
|
|
|
|
Investors
/ |
|
Holders: |
|
|
|
|
|
|
|
|
|
Name
: |
|
* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
|
/s/ Jeanne Larkin Henry |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Print Name: |
|
Jeanne Larkin Henry |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title: |
|
Vice-President |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ATLAS VENTURE FUND III,
L.P. |
|
|
||
|
ATLAS VENTURE
ENTREPRENEURS’ FUND III, L.P. |
|
|
||
|
By: |
|
Atlas Venture Associates
III, L.P. |
|
|
|
|
|
its general partner |
|
|
|
By: |
|
Atlas Venture Associates
III, L.P. |
|
|
|
|
|
its general partner |
|
|
|
|
|
|
|
|
|
ATLAS VENTURE FUND IV, L.P. |
|
|
||
|
ATLAS VENTURE PARALLEL FUND
IV — A, C.V. |
|
|
||
|
ATLAS VENTURE PARALLEL FUND
IV — B, C.V. |
|
|
||
|
ATLAS VENTURE ENTREPRENEURS’
FUND IV, L.P. |
|
|
||
|
By: |
|
Atlas Venture Associates
IV, L.P. |
|
|
|
|
|
its general partner |
|
|
|
By: |
|
Atlas Venture Associates
IV, Inc. |
|
|
|
|
|
its general partner |
|
|
[Signature Page to First
Amendment to Amended and Restated Investor Rights Agreement]
In Witness Whereof, the parties
hereto have executed this First
Amendment to the Amended and Restated Investor Rights Agreement
effective as of the day and year first set forth above.
|
|
|
|
|
|
|
Investors/Holders: |
|
|
||
|
|
|
|
|
|
|
Name
: |
|
Bavp,
L.P. |
|
|
|
|
|
|
|
|
|
By: |
|
/s/ Louis C. Bock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Print Name: |
|
Louis C. Bock |
|
|
|
|
|
|
|
|
|
Title: |
|
Managing Director |
|
|
[Signature Page to First
Amendment to Amended and Restated Investor Rights Agreement]
In Witness Whereof, the parties
hereto have executed this First
Amendment to the Amended and Restated Investor Rights Agreement
effective as of the day and year first set forth above.
|
|
|
|
|
|
|
Investors/Holders: |
|
|
||
|
|
|
|
|
|
|
Name
: |
|
Caduceus
Private Investments, LP |
|
|
|
|
|
|
|
|
|
By: |
|
/s/ Eric A. Bittelman |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Print Name: |
|
Eric A. Bittelman |
|
|
|
|
|
|
|
|
|
Title: |
|
CFO, OrbiMed Capital LLC,
General Partner |
|
|
[Signature Page to First
Amendment to Amended and Restated Investor Rights Agreement]
In Witness Whereof, the parties
hereto have executed this First
Amendment to the Amended and Restated Investor Rights Agreement
effective as of the day and year first set forth above.
|
|
|
|
|
|
|
Investors/Holders: |
|
|
||
|
|
|
|
|
|
|
Coleman Swenson Hoffman
Booth IV L.P. |
|
|
||
|
By: |
|
Its General Partner, |
|
|
|
|
|
CSHB Ventures IV L.P. |
|
|
|
|
|
|
|
|
|
By: |
|
/s/ Larry H. Coleman Its: General Partner |
|
|
|
|
|
|
|
|
|
Print Name: |
|
Larry H. Coleman |
|
|
|
|
|
|
|
|
|
Title: |
|
General Partner |
|
|
[Signature Page to First
Amendment to Amended and Restated Investor Rights Agreement]
In Witness Whereof, the parties
hereto have executed this First
Amendment to the Amended and Restated Investor Rights Agreement
effective as of the day and year first set forth above.
|
|
|
|
|
|
|
Investors/Holders: |
|
|
||
|
|
|
|
|
|
|
Name
: |
|
Walter
T. Dec |
|
|
|
|
|
|
|
|
|
By: |
|
/s/ Walter T. Dec |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Print Name: |
|
Walter T. Dec |
|
|
|
|
|
|
|
|
|
Title: |
|
Sir |
|
|
[Signature Page to First
Amendment to Amended and Restated Investor Rights Agreement]
In Witness Whereof, the parties
hereto have executed this First
Amendment to the Amended and Restated Investor Rights Agreement effective
as of the day and year first set forth above.
|
|
|
|
|
|
|
Investors/Holders: |
|
|
||
|
|
|
|
|
|
|
Name
: |
|
/s/
Ken Dill Joland Schreurs |
|
|
|
|
|
|
|
|
|
By: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Print Name: |
|
Ken Dill Joland Schreurs |
|
|
|
|
|
|
|
|






